Fundamental Analysis of Tekla Life Sciences Investors - Growth / Value Index
HQL - Valuation Highlights
Valuation Analysis
Tsr Value Index - Very Poor Score of 14.29
Book Value in last 3 years is trending down
Valuation Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Price to Earning | 33.78 | 16.90 | 640.88 % | |
| Price to Book | 0.905 | 0.940 | 14.42 % | 0.964 |
| Price to Sales | 5.96 | 16.06 | 607.30 % | |
| Enterprise Value to EBITDA Multiple | 33.77 | 16.90 | 640.87 % |
HQL - Profitability Highlights
Profitability Analysis
Gives Dividend Yield of 9.60 %
Net profit has jumped from negative to positive
Piotroski F Score - Stable Value of 4.0
Good Net Margin of 17.64% is achieved by the company
Tsr Profitability Index - Poor Score of 20.83
Low Earning Yield of 2.97 %
Negative Net Margin MRQ
Profitability Key Ratios
| Ratio | TTM | Latest FY | Yoy Change | MRQ |
|---|---|---|---|---|
| Return On Equity | 2.68 | 5.56 | 121.15 % | -2.85 |
| Return On Asset | 2.61 | 5.55 | 122.01 % | -2.84 |
| Net Profit Margin | 17.64 | 95.02 | -6.21 % | -38.73 |
| Operating Profit Margin | -10.35 | 95.02 | -6.21 % | -38.72 |
| EBITDA Margin | 18.41 | 95.02 | -6.21 % | -38.72 |
Highlights
| Market Cap | 385642 K |
| Enterprise Value | 385641 K |
| Price/Book TTM | 0.905 |
| Outstanding Share | 27350.50 K |
| Float/ Outstanding Share | 0% |
| Dividend Yield | 9.32 % |
Share Holding
Guru Numbers
| Price/Graham No | 1.19 |
| Peter Lynch Ratio | 0 |
| Piotroski F Score | 4.00 |
| Altman Z Score | 347.16 |
| Sloan Ratio | 0.056 |
| Peter Lynch Fair Value | 0 |
HQL - Growth Highlights
Growth Analysis
Quarterly sales in last 5 years is trending up
Company's Total Assets is Decreasing for last 3 years
Growth Key Fields
| Field | TTM | YoY Growth | QoQ Growth |
|---|---|---|---|
| Revenue | 62040.66 K | 122.78 % | 201.03 % |
| Gross Profit | 54153.46 K | 122.78 % | 276.35 % |
| EBITDA | 11418.92 K | 121.37 % | 133.87 % |
| Net Profit | 10946.87 K | 121.37 % | 133.87 % |
| EPS | 0.417 | 118.49 % | NA |
HQL - Stability Highlights
Stability Analysis
Tsr Stability Index - Excellent Score of 95.00
Altman Z Score of 345.93 suggests good Stability
Company is Debt Free
Interest Coverage of 0
Stability Key Ratios
| Ratio | Latest FY | Yoy Change | MRQ |
|---|---|---|---|
| Debt to Equity Ratio | 0 | 0 % | 0.0000 |
| Cash Ratio | 0 | 0 % | |
| Quick Ratio | 0 | 0 % | -1.52 |
| Shareholders Equity | 99.83 | 4.06 % | |
| Debt to EBITDA | 0 | 0 % |
Historical Valuation Ratios of Tekla Life Sciences Investors
Historical Valuation Ratios
Loading ...
Historical Profitability Ratios of Tekla Life Sciences Investors
Historical Profitability Ratios
Loading ...
Historical Efficiency Ratios of Tekla Life Sciences Investors
Historical Efficiency Ratios
Loading ...
Historical Solvency Ratios of Tekla Life Sciences Investors
Historical Solvency Ratios
Loading ...
Note : All Data Generated at the End of Trading Hours (EOD Data)